In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients

European Journal of Nuclear Medicine

Volumn 24, Issue 2, 1997, Pages 150-159

  Del Vecchio, Silvana ^a,d,e   Ciarmiello, Andrea ^b   Potena, Maria I ^b   Carriero, Maria V ^b   Mainolfi, Ciro ^a,d   Botti, Gerardo ^b   Thomas, Renato ^b   Cerra, Maria ^b   D'Aiuto, Giuseppe ^b   Tsuruo, Takashi ^c   Salvatore, Marco ^a,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF TOKYO   (Japan)

^d CNR   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Breast carcinoma; Multidrug resistance; P glycoprotein; Technetium 99m sestamibi

Indexed keywords

GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; BREAST CANCER; BREAST EXAMINATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EFFUSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PHENOTYPE;

AUTORADIOGRAPHY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; P-GLYCOPROTEIN; PHENOTYPE; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0012729237     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02439547     Document Type: Article

References (41)

1. Kartner N, Evernden-Porelle D, Bradley G, Ling V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibody. Nature 1985; 316: 820-823.
2. Gottesman MM, Pastan I. The multidrug transporter, a double-edged sword. J Biol Chem 1988; 263: 12163-12166.
3. Van der Bliek AM, Borst P. Multidrug resistance. Adv Cancer Res 1989; 52: 165-202.
4. Shen DW, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I, Gottesman MM. Human multidrug-resistant cell lines: increased mdr 1 expression can precede gene amplification. Science 1986; 232: 643-645.
5. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987; 84: 265-269.
6. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987; 84: 7735-7738.
7. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai S-L, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81: 116-124.
8. Weinstein RS, Hansen KK, McBeath RB, Dalton WS. Expression of the MDR1 gene (P-glycoprotein) in breast cancer. Recent Results Cancer Res 1993; 127: 49-54.
9. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976, 455: 152-162.
10. Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB. Internal duplication and homology with bacterial transport proteins in the mdr 1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986; 47: 381-389.
11. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993; 53: 977-984.
12. Wackers FJT, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, Boucher CA, Picard M, Holman BL, Fridrich R, Inglese E, Delaloye B, Bischof-Delaloye A, Camin L, McKusick K. Tc-99m-hexakis 2-methoxy isobutylisonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301-311.
13. Hassan IM, Sahweil A, Constantinides C, Mahmoud A, Nair M, Omar YT, Abdel-Dayem HM. Uptake and kinetics of Tc-99m hesakis 2-methoxy isobutylisonitrile in benign and malignant lesions of the lungs. Clin Nucl Med 1989; 14: 333-340.
14. Caner B, Kitapel M, Unlu M, Erbengi G, Calikoglu T, Gogus T, Bekdik C. Tc-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with Tc-99m-MDP. J Nucl Med 1992; 33: 319-324.
15. Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi. Eur J Nucl Med 1994; 21: 357-362.
16. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, Jackson B, Klein S. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995; 36: 1784-1789.
17. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the cation hexakis (2 methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50: 2198-2202.
18. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxy isobutyl isonitrile) technetium(I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation 1990; 82: 1826-1838.
19. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis(2-methoxyisobutylisonitrile) technetium in cultured mouse fibroblasts. J Nucl Med 1990; 31: 1646-1653.
20. Hartmann WH, Ozzello L, Sobun LH, Stalsberg H. Histological typing of breast tumors, 2nd edn. Geneva: WHO, 1981.
21. Black MM, Speer FD. Nuclear structure in cancer tissues. Surg Gynecol Obstet 1957; 105: 97-102.
22. EORTC Breast Cancer Cooperative Group. Standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 1980; 16: 1513-1515.
23. Bates S, Lee JS, Dickestein B, Spolyer M, Fojo AT. Differential modulation of P-glycoprotein transport by protein kinase inhibition. Biochemistry 1993; 32: 9156-9164.
24. Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M. Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography. J Nucl Med 1996; 37: 665-672.
25. Hamada H, Tsuruo T. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 1986; 83: 7785-7789.
26. Georges E, Tsuruo T, Ling V. Topology of P-glycoprotein as determined by epitope mapping of MRK16 monoclonal antibody. J Biol Chem 1993; 268: 1792-1798.
27. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6-tetrachloro-3α,6α-diphenylglycouril. Biochem Biophys Res Commun 1978; 80: 849-857.
28. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 1984; 72: 77-89.
29. r 97,000 and 250,000 protein antigen concentration in sections of human melanoma using in vitro quantitative autoradiography. Cancer Res 1988; 48: 5475-5481.
30. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580.
31. Colton T. Statistics in medicine. Boston: Little, Brown and Co., 1974.
32. 99mTc-sestamibi as an agent for imaging P-glycoprotein-mediated multidrug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl Med Commun 1995; 16: 253-257.
33. Scala S, Saeki T, Lynch A, Salomon D, Merino MJ, Bates S. Coexpression of TGFα, epidermal growth factor receptor, and P-glycoprotein in normal and benign diseased breast tissues. Diagn Mol Pathol 1995; 4: 136-142.
34. Charpin C, Vielh P, Duffaud F, Devictor B, Andrac L, Lavaut MN, Allasia C, Horschowski, Piana L. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and immunohistochemical prognostic indicators. J Natl Cancer Inst 1994; 86: 1539-1545.
35. Levchenko A, Metha BM, Spengler BA, Narkar AA, Fonti R, Biedler JL, Tsuruo T, Larson SM. Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay. Anal Biochem 1996; 236: 338-343.
36. Young AB, Frey KA, Agranoff BW. Receptor assay: in vitro and in vivo. In: Phelps M, Mazziotta J, Schelbert H, eds. Positron emission tomography and autoradiography: principles and applications for the brain and heart. New York: Raven Press; 1986: 73-111.
37. Del Vecchio S, Stoppelli P, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, Salvatore M. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res 1993; 53: 3198-3206.
38. Chan HSL, Haddad G, Thorner PS, DeBoer G, Lin YP, Ondrusek N, Yeger H, Ling V. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 1991; 325: 1608-1614.
39. Valverde MA, Diaz M, Sepulveda FV, Gill DR, Hyde SC, Higgins C. Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein. Nature 1992; 355: 830-833.
40. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceci RJ, Kramer R, Guidotti G, Cantiello HF. The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci USA 1993; 90: 312-316.
41. Chambers TC, McAvoy EM, Jacobs JW, Eilon G. Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J Biol Chem 1990; 265: 7679-7686.